Search by

Case Studies

Podcasts & Webinars

Play Video

Navigating the Future — Pharma, Analytics Maturity and Shaping Healthcare’s Use of AI

Learn all about the roadmap to data maturity and AI adoption to get maximum value from your patient-centric intelligence.

Patient-Centric Brand Growth with ChatGPT, Predictive AI and On-Demand Patient Journey

Explore the transformative power of AI, GPT and predictive analytics and how it can benefit patient-centric brand growth.

A Healthy Dose of Data Science

Check out Tech Wire Asia podcast featuring Prospection's Co-CEO & Co-Founder, Eric Chung, as he discusses how Prospection is using...

Longitudinal Patient Data - Addressing Common Questions & Unlocking the Value of Real-World Data

Pharmaceutical companies work with many different types of data ranging from commercial sales through to longitudinal patient data. In this...

RWD providing answers to real world questions

Real world data provides patient and disease insights. Prospection Co-founders, Eric Chung, CEO and Dr Peter Cronin, Head of Data...

Data to Real World Evidence

A Prospection Podcast with Dr Peter Cronin. What does it mean to be a trusted 3rd party provider? Prospection operates...

Improving Patient Outcomes

Exploring the field of real world evidence generation. How turning real world data into evidence is improving the patient outcomes....

Publications

Real-World Study: Treatment Persistence in Pulmonary Arterial Hypertension Patients

comparative effectivenessERAsPAHreal world evidence

Real world use of antipsychotic medication

A recent publication using Prospection’s real-world data analytics shows, 1 in 5 Australian patients with schizophrenia [1] is medicated with older typical long acting injectable (LAI) antipsychotics. Schizophrenia is one of th...

antipsychoticspatient outcomesreal world evidenceschizophrenia

Are high coronary risk patients missing out on lipid-lowering drugs in Australia?

high coronary risklipid-lowering drugs

White Papers

No data was found